Sunday morning, same routine for four months straight: the jab, a small sting in my thigh, then breakfast. I kept it up right through the week of my hysterectomy because I didn’t want to lose momentum on the twenty-two pounds I’d already dropped. Then, less than an hour before I was due in theatre, the anaesthetist walked in, looked at my chart, and said we needed to talk about what might still be sitting in my stomach. That’s when it clicked: the drug that had been quietly switching off my appetite for months hadn’t switched off. It had just been waiting for a moment when an Empty Stomach actually mattered.
What she was describing wasn’t a rare fluke. GLP-1 medications are used for weight loss because they delay gastric emptying, decreasing hunger and reducing how much people eat. That’s precisely why they work so well for appetite control, and precisely why they’ve become a genuine headache for anesthesiologists. The primary concern in patients undergoing surgery who have appropriately fasted is the slowing of gastric motility, which causes retained food or liquid in the stomach, and research has identified a higher occurrence of residual stomach contents in appropriately fasted patients taking these drugs compared to those not on a GLP-1 receptor agonist. In one study looking at patients scheduled for elective procedures, researchers calculated that 56% of people using GLP-1 receptor agonists showed increased residual gastric content, compared to 19% of those not taking the medication. Fasting from midnight, doesn’t guarantee an empty stomach anymore. It just guarantees you followed the old rules for a drug that changed the game.
Key takeaways
- A routine weight-loss jab nearly derailed a planned surgery when pre-operative fasting failed to empty the stomach
- Medical guidance on GLP-1 drugs and surgery has completely flipped twice in two years—leaving patients confused about what to do
- An ultrasound scan before surgery, not stopping the injection, is now the safest approach according to five major medical societies
Why an Empty Stomach Suddenly Isn’t So Empty
Under general anesthesia, your body loses the reflexes that normally protect your airway. If there’s still food or liquid sloshing around in your stomach, it can travel back up and into your lungs. Anaesthetists must be aware of a potentially dangerous side effect of the drug, decreased gastric emptying, caused by effects on gastric smooth muscle mediated by the vagal afferent nerves. That’s aspiration, and it’s not a minor complication. Aspiration of stomach contents into the lungs is dangerous and can be life-threatening.
The medical literature isn’t short of unsettling case reports either. One published account described two cases of peri-operative regurgitation of gastric contents in patients taking semaglutide, where a patient may have a full stomach despite compliance with routine pre-operative fasting guidelines. In one of those cases, imaging after the event showed bilateral infiltrates with fluid in the dependent segment of the right lower lobe, essentially a lung soaked with stomach contents. The FDA took notice too. Drug labels for the major GLP-1 medications, from Ozempic to Mounjaro, were updated to include rare postmarketing reports of pulmonary aspiration associated with their use in patients undergoing elective procedures requiring general anesthesia or deep sedation who had residual gastric contents despite preoperative fasting.
The Guidance Keeps Shifting Under Everyone’s Feet
Here’s the part that catches so many patients off guard: the official advice has actually flipped since these drugs first raised alarm bells. Back in 2023, the American Society of Anesthesiologists issued its first consensus guidance, and it leaned cautious. Given the concerns of GLP-1 agonist-induced delayed gastric emptying and associated high risk of regurgitation, the task force suggested holding the drugs before elective procedures, while for urgent or emergent procedures patients should simply be treated as having a full stomach. That’s the “stop it for a week beforehand” advice that circulated widely, and which I’d half-heard about but assumed didn’t apply to me because I felt fine.
Except by late 2024, five major medical societies, including the ASA and the American Gastroenterological Association, walked that blanket advice back. Most patients should continue taking their GLP-1 receptor agonists before elective surgery, according to the new clinical guidance, though patients at the highest risk for significant gastrointestinal side effects should follow a liquid diet for 24 hours before the procedure or other measures. The reasoning is sensible once you sit with it: stopping the injection cold for a week doesn’t necessarily empty a stomach that’s been sluggish for months, and abrupt interruptions can destabilize blood sugar in diabetic patients. The guidance notes the team can minimize the risk of delayed stomach emptying by having the patient follow a liquid-only diet for 24 hours before surgery, adjusting the anesthesia plan to minimize aspiration risk, and using point-of-care ultrasound right before the procedure to assess stomach contents in patients at highest risk. In the UK, similar caution now applies. The MHRA has warned that GLP-1 and dual GIP/GLP-1 medicines may increase the risk of residual stomach contents during general anaesthesia or deep sedation, even after standard fasting.
What This Actually Means If You’ve Got a Jab and a Surgery Date
My own procedure went ahead that morning, just later than planned and with a bedside ultrasound scan first to check whether my stomach was clear. That’s increasingly standard practice: an ultrasound the day of surgery can assess whether your stomach is empty, and if it isn’t, or the results aren’t clear, the anesthesiologist can either proceed using so-called full-stomach precautions, which alter how general anesthesia is administered, or postpone the surgery. The single most useful thing I’d do differently next time is tell every single person on my care team, unprompted, exactly which jab I’m on and when I last took it. Patients are advised to tell their healthcare team and anaesthetist if they are taking these medicines, and a safe plan should be agreed between the prescribing clinician, surgical team and anaesthetist. Nobody had asked me directly during my initial consult, and I hadn’t thought to volunteer it, because in my head it was a diet injection, not a medication with anesthesia implications.
One detail rarely mentioned in the panic headlines: even patients who dutifully paused their weekly dose still turned up with a full stomach on ultrasound. A pediatric case report described a patient who had held semaglutide for 12 days, completed bowel preparation, and fasted from solids for 32 hours and clear liquids for 10 hours, and still showed a stomach full of fluid and particulate matter on the scan. Stopping the jab isn’t a guarantee. The scan, the honest conversation with your anesthetist, and a willingness to eat only liquids the day before, that combination does far more for your safety than white-knuckling through a week without your injection ever will.
Sources : asahq.org | ncbi.nlm.nih.gov